APA (7th ed.) Citation

Hemme J. Hijma, Emilie M. J. vanBrummelen, Pieter S. Siebenga, & Geert Jan Groeneveld. (2022). A phase I, randomized, double‐blind, placebo‐controlled, single‐ and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX‐128, a highly selective Nav1.8 inhibitor, in healthy adults. Wiley.

Chicago Style (17th ed.) Citation

Hemme J. Hijma, Emilie M. J. vanBrummelen, Pieter S. Siebenga, and Geert Jan Groeneveld. A Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐ and Multiple Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of VX‐128, a Highly Selective Nav1.8 Inhibitor, in Healthy Adults. Wiley, 2022.

MLA (9th ed.) Citation

Hemme J. Hijma, et al. A Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐ and Multiple Dose Escalation Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of VX‐128, a Highly Selective Nav1.8 Inhibitor, in Healthy Adults. Wiley, 2022.